What is BioCardia Effective Interest Rate on Debt %?
Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. BioCardia's annualized positive value of Interest Expense for the quarter that ended in Dec. 2024 was $0.00 Mil. BioCardia's average total debt for the quarter that ended in Dec. 2024 was $1.00 Mil. Therefore, BioCardia's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 was 0.00%.
BioCardia Effective Interest Rate on Debt % Historical Data
The historical data trend for BioCardia's Effective Interest Rate on Debt % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioCardia's Effective Interest Rate on Debt %
For the Biotechnology subindustry, BioCardia's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioCardia's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioCardia's Effective Interest Rate on Debt % distribution charts can be found below:
* The bar in red indicates where BioCardia's Effective Interest Rate on Debt % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data,
the Interest Expense data used here is four times the quarterly (Dec. 2024) interest expense data.
Effective Interest Rate on Debt % is displayed in the 30-year financial page.
BioCardia (NAS:BCDA) Effective Interest Rate on Debt % Explanation
Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.
BioCardia Effective Interest Rate on Debt % Related Terms
Thank you for viewing the detailed overview of BioCardia's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BCDA has been successfully added to your 